Vin Singh, Founder and CEO of BullFrog AI Holdings, Inc. BFRG, was recently a guest on Benzinga’s All Access.
BullFrog AI is a clinical-phase biotechnology company using machine learning to advance medicine and improve human health. The company uses technology developed in the Applied Physics Lab at Johns Hopkins.
With these powerful AI tools, BullFrog hopes to change the way drugs are developed and administered, making them tailor-made. This paradigm shift could have huge impacts on the efficacy of medicines.
Watch the full interview here:
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice
Featured photo by Austin Santaniello on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.